Saccadic paradigms in restless legs syndrome with and without augmentation: An eye-tracking study
Philipp Ellmerer1, Beatrice Heim1, Ambra Stefani1
1Department of Neurology, Medical University of Innsbruck.
Neuropsychology
|August 13, 2026
Summary
Eye-tracking tasks reveal executive dysfunction and impulsivity in restless legs syndrome (RLS) patients with augmentation. This suggests eye tracking may help monitor dopaminergic therapy in RLS.
Area of Science:
- Neuroscience
- Ophthalmology
- Psychiatry
Background:
- Restless Legs Syndrome (RLS) is a neurological disorder.
- Long-term dopaminergic therapy for RLS can lead to augmentation and impulse control disorders.
- Executive dysfunction and impulsivity are potential consequences of augmentation.
Purpose of the Study:
- To investigate the utility of saccadic eye movement paradigms in detecting impulsivity and executive dysfunction in RLS patients.
- To specifically assess RLS patients experiencing augmentation due to dopaminergic therapy.
Main Methods:
- A cohort of 47 nondemented RLS patients and 20 healthy controls (HC) were recruited.
- Patients were divided into RLS controls (no augmentation) and RLS + AUG (with augmentation).
- An eye-tracking battery including prosaccade, antisaccade, and stop signal tasks was administered to all participants.
Main Results:
- RLS + AUG patients showed significantly higher error rates in all saccadic tasks compared to HC, indicating impaired inhibitory control.
- RLS controls had error rates similar to HC.
- While overall reaction times did not differ, RLS + AUG patients exhibited longer reaction times on correct antisaccade trials.
Conclusions:
- RLS + AUG patients demonstrate deficits in oculomotor response inhibition, suggesting executive dysfunction and increased impulsivity.
- These findings highlight the potential of eye tracking as a clinical tool for monitoring dopaminergic therapy in RLS.
- Further longitudinal studies with larger cohorts are needed to explore the temporal relationship between dopaminergic exposure, augmentation, and impulse control symptoms.


